AVNS vs ITGR

For growth investors, Integer Holdings Corporation (ITGR) is the stronger pick with 7.

6% revenue growth year-over-year, versus 1. 9% for Avanos Medical, Inc. (AVNS). Integer Holdings Corporation (ITGR) offers the better valuation at 30. 4x trailing P/E (13. 5x forward), making it the more compelling value choice. Analysts rate Integer Holdings Corporation (ITGR) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Integer Holdings Corporation is actually cheaper at 13.

5x.

Over the past 5 years, Integer Holdings Corporation (ITGR) delivered a total return of -7.

5%, compared to -39. 8% for Avanos Medical, Inc. (AVNS). Over 10 years, the gap is even starker: ITGR returned +165. 1% versus AVNS's -17. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Integer Holdings Corporation (ITGR) is the lower-risk stock at 0.

72β versus Avanos Medical, Inc. 's 1. 54β — meaning AVNS is approximately 115% more volatile than ITGR relative to the S&P 500. On balance sheet safety, Avanos Medical, Inc. (AVNS) carries a lower debt/equity ratio of 17% versus 80% for Integer Holdings Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Integer Holdings Corporation (ITGR) is pulling ahead at 7.

6% versus 1. 9% for Avanos Medical, Inc. (AVNS). On earnings-per-share growth, the picture is similar: Avanos Medical, Inc. grew EPS 82. 9% year-over-year, compared to -15. 0% for Integer Holdings Corporation. Over a 3-year CAGR, ITGR leads at 11. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Integer Holdings Corporation (ITGR) is the more profitable company, earning 5.

6% net margin versus -9. 7% for Avanos Medical, Inc. — meaning it keeps 5. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ITGR leads at 11. 3% versus -8. 8% for AVNS. At the gross margin level — before operating expenses — AVNS leads at 49. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Integer Holdings Corporation (ITGR) trades at 13.

5x forward P/E versus 24. 8x for Avanos Medical, Inc. — 11. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ITGR: 11. 5% to $98. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Integer Holdings Corporation (ITGR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

72), +165. 1% 10Y return). Avanos Medical, Inc. (AVNS) carries a higher beta of 1. 54 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ITGR: +165. 1%, AVNS: -17. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.